NASDAQ:BIB

Proshares Ultra Nasdaq Biotechnology ETF Forecast

etoro logo Buy BIB
*Your capital is at risk
$106.84
+6.08 (+6.03%)
At Close: Jul 02, 2026
AI Analysis AI Analysis of BIB AI-Powered Market Insights
ETF Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BIB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

On Thursday, ProShares Ultra Nasdaq Biotechnology ETF price gained an impressive 6.03%
(Updated on Jul 02, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 11, 2026 Gain 29.86%

The ProShares Ultra Nasdaq Biotechnology ETF price gained 6.03% on the last trading day (Thursday, 2nd Jul 2026), rising from $100.76 to $106.84. It has now gained 10 days in a row. It is not often that ETFS manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the ETF fluctuated 3.57% from a day low at $103.23 to a day high of $106.92. The price has risen in 10 of the last 10 days and is up by 25.76% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 20 thousand shares were bought and sold for approximately $2.17 million.

The ETF has broken the wide and weak rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $96.46, a level that may pose a second chance to hit a runner. According to fan-theory $113.40 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

BIB Signals & Forecast

The ProShares Ultra Nasdaq Biotechnology ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $99.08 and $85.65. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 39.31%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for ProShares Ultra Nasdaq Biotechnology ETF

On the downside, the ETF finds support just below today's level from accumulated volume at $98.28 and $89.74. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, ProShares Ultra Nasdaq Biotechnology finds support just below today's level at $98.28. If this is broken, then the next support from accumulated volume will be at $89.74 and $82.90.

This ETF may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this ETF is considered to be "high risk". During the last day, the ETF moved $3.69 between high and low, or 3.57%. For the last week, the ETF has had daily average volatility of 3.24%.

The ProShares Ultra Nasdaq Biotechnology ETF is extremely overbought on RSI14 (98). Normally this may pose a good selling opportunity but since the ETF has broken the trend up, the chance for a major correction due to high RSI is very small as the ETF will find support at the trend broken. Since the ProShares Ultra Nasdaq Biotechnology has been rising for 10 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Our recommended stop-loss: $102.29 (-4.25%) (This ETF has high daily movements and this gives high risk. The RSI14 is 98 and this increases the risk substantially. There is a buy signal from a pivot bottom found 21 days ago.)

Trading Expectations (BIB) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect ProShares Ultra Nasdaq Biotechnology to open at $105.66, and during the day (based on 14 day Average True Range), to move between $105.17 and $108.51, which gives a possible trading interval of +/-$3.34 (+/-3.18%) up or down from last closing price. If ProShares Ultra Nasdaq Biotechnology takes out the full calculated possible swing range there will be an estimated 3.18% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $98.28, some $8.56 (8.01%) from the current price of $106.84, our system finds the risk reward attractive.

Is ProShares Ultra Nasdaq Biotechnology ETF A Buy?

ProShares Ultra Nasdaq Biotechnology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $105.66 ( 1.10%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BIB Performance

Trading levels for BIB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 109.35 2.35%
R2 107.94 1.03%
R1 107.07 0.219%
Price 106.84
S1 104.25 -2.42%
S2 103.38 -3.23%
S3 101.97 -4.55%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 106.84
S1 98.28 -8.01%
S2 89.74 -16.00%
S3 82.90 -22.41%

BIB Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 25, 2026 Mar 25, 2026 Mar 31, 2026 $0.0071 0.0091%
2 Dec 23, 2025 Dec 24, 2025 Dec 31, 2025 $0.135 0.163%
3 Sep 23, 2025 Sep 24, 2025 Sep 30, 2025 $0.181 0.326%
4 Jun 24, 2025 Jun 25, 2025 Jul 01, 2025 $0.171 0.368%
5 Mar 25, 2025 Mar 26, 2025 Apr 01, 2025 $0.131 0.287%

FAQ

What is the symbol for ProShares Ultra Nasdaq Biotechnology ETF and on which exchange is it traded?
The symbol for ProShares Ultra Nasdaq Biotechnology is BIB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProShares Ultra Nasdaq Biotechnology ETF?
ProShares Ultra Nasdaq Biotechnology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy ProShares Ultra Nasdaq Biotechnology ETF?
ProShares Ultra Nasdaq Biotechnology ETF can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProShares Ultra Nasdaq Biotechnology ETF.

What's the current price of ProShares Ultra Nasdaq Biotechnology ETF?
As of the end of day on the Jul 02, 2026, the price of an ProShares Ultra Nasdaq Biotechnology (BIB) share was $106.84.

What is the 52-week high and low for ProShares Ultra Nasdaq Biotechnology ETF?
The 52-week high for ProShares Ultra Nasdaq Biotechnology ETF is $106.92 and the 52-week low is $46.37.

What is the market capitalization of ProShares Ultra Nasdaq Biotechnology ETF?
As of the Jul 02, 2026, the market capitalization of ProShares Ultra Nasdaq Biotechnology is 88.672M.
Click to get the best stock tips daily for free!
ABOUT PROSHARES ULTRA NASDAQ BIOTECHNOLOGY
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are c...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE